
Product Specifications
Bosutinib is a small molecule bcr-abl and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by wyeth, it is being developed by pfizer bosutinib is a small molecule bcr-abl and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by wyeth, it is being developed by pfizer
Company Information
Ask for more detail from the seller
Contact Supplier